博士生导师 主任医师
Doctor’s Supervisor, Chief Physician,
同济大学附属同济医院 肿瘤科 科主任
Director of Department of Oncology, Tongji Hospital Affiliated to Tongji University
【学术任职】（Academic Participation）
1.上海市抗癌协会肿瘤生物治疗专委会副主任委员
Vice chairman of Tumor Biotherapy Branch Committee of Shanghai Anti-Cancer Association
2.上海市医学会肿瘤内科专科分会 委员
Member of Oncology Branch Committee, Shanghai Medical Association
3.中国医师协会结直肠肿瘤内科专委会 委员
Member of Colorectal Cancer Committee of Chinese Medical Doctor Association
4.上海市抗癌协会 理事
Member of Shanghai Anti-Cancer Association
5.上海女医师协会肺癌专委会 常务委员
Standing Member of Lung cancer Committee of Shanghai Medical Women
主持国家自然科学基金面上项目1项，国家卫健委基金项目1项，江西省自然科学基金面上项目1项，上海市卫健委面上项目2项。发表SCI论文10余篇，最高影响因子10.435。
She presided over one general project of National Natural Science Foundation of China (NSFC), one project of the National Health Commission, one general project of the Jiangxi Provincial Natural Science Foundation of China, and two general projects of the Shanghai Municipal Health Commission. She has recently published over 10 SCI papers, with the highest impact factor of 10.435.
项目
国家自然科学基金面上项目（编号：82073033）FAP阳性CAFs通过GREM1/TGF-β信号通路促进胃癌细胞EMT导致恶性进化的机制研究 课题负责人,经费55万元,2021.1～2024.12
Molecular Mechanism of FAP Positive CAFs Promoting EMT of Gastric Cancer Cell Through GREM1/TGF-β Signaling Pathways，2021.1-2024.12，Leader.
江西省自然科学金面上项目（编号：20181BAB205045）RNA结合蛋白hMex-3A在胃癌中的作用和分子机制研究 课题负责人,经费6万元,2018.1～2020.12
The function of RNA-binding protein hMex-3A in gastric cancer and its underline molecular mechanism，2018.1～202012，Leader.
上海市卫生和计划生育委员会中医药三年行动计划重大临床研究项目（编号：ZY（2018-2020）-CCCX-4013）缓控释靶向给药技术在中医预防胃癌术后复发转移治疗中的应用研究
课题负责人,经费20万元,2018.1～2020.12
Application of slow / controlled release and targeted drug delivery in traditional Chinese medicine to prevent postoperative recurrence and metastasis of Gastric Cancer,2018.1～2020.12，Leader.
上海市卫生和计划生育委员会科研课题面上项目（编号：201740038）外周血外秘体FRLnc1在胃癌早期诊断中的应用研究 课题负责人,经费20万元,2018.1～2020.12
Application of human peripheral blood-derived exosomes FRLnc1 in the early diagnosis of gastric cancer. ,2018.1～2020.12，Leader.
卫生部医药卫生科技发展研究资助基金（编号：W2012FZ052）分子诊断技术在结直肠癌个体化治疗中的应用研究 课题负责人,经费30万元,2012.3～2014.2
Application of molecular diagnosis technology in individualized treatment of colorectal cancer, 2012.3～2014.2, Leader.
论文(近5年)
Zhang Y, Chen L, Ye X, Wu Z, Zhang Z, Sun B, Fu H, Fu C, Liang X, Jiang H(姜虹,通讯作者).Expression and mechanism of exosome-mediated A FOXM1 related long noncoding RNA in gastric cancer.J Nanobiotechnol.2021;19(1):133-149. (IF:10.435)
Wu ZX,Jiang H(姜虹,并列第一),Fu H,Zhang Y.A circGLIS3/miR-644a/PTBP1 positive feedback loop promotes the malignant biological progressions of non-small cell lung cancer.Am J Cancer Res.2021;11(1):108-122. (IF:6.170)
Chen J,Chen L,Du SB,Wu J,Quan M,Yin H,Wu Y,Ye XT,Liang XF,Jiang H(姜虹,通讯作者).High sensitive detection of circulating tumor cell by multimarker lipid magnetic nanoparticles and clinical verificationsigh sensitive detection of circulating tumor cell by multimarker lipid magnetic nanoparticles and clinical verifications.J Nanobiotechnol.2019;17(1):116-127. (IF:10.435)
Zhuang W,Ma JX,Chen XD,Wang GQ,Lu J,Chen YN,Dong Hua,Cai SL,Zhang YZ,Jiang H(姜虹,并列通讯作者),Wang ZJ.The Tumor Mutational Burden of Chinese Advanced patients Estimated by a 381-cancer-gene panel.J Cancer.2018;9(13):2302-07. (IF：3.429)
Chen L,Jiang H(姜虹,并列第一),Gao W,Tu Y,Zhou Ying,Li X,Zhu Z,Jiang QX,Zhan HF,Yu JM,Fu CG,Gao Y.Combination with intravenous iron supplementation or doubling erythropoietin dose for patients with chemotherapy-induced anaemia inadequately responsive to initial erythropoietin treatment alone:study protocol for a randomise controlled trial.BMJ Open.2016,12(8):1356-62.(IF:2.369)
